RecruitingNot ApplicableNCT06495021

How OMT Benefits Newly Diagnosed Patients With Respiratory Illness When Given Alongside Other Standard Care.

OMT and Respiratory Illness


Sponsor

Geisinger Clinic

Enrollment

68 participants

Start Date

Dec 31, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

This study is to see Osteopathic Manipulative Therapy, or OMT, can aid in treating patients being seen for respiratory illness and associated symptoms. The hypothesis is that the addition of OMT therapy, alongside other standard care (such as a medication), can help lessen patient symptoms sooner than just other treatment alone, and the duration of the condition will shorten as well.


Eligibility

Min Age: 65 YearsMax Age: 100 Years

Inclusion Criteria3

  • Patients being seen for respiratory illness symptoms at Geisinger 65-Forward Buckhorn, PA clinic for care.
  • Patients age of 65-100
  • New diagnosis of upper respiratory illness, sinusitis, bronchitis, or pneumonia during outpatient visit.

Exclusion Criteria3

  • Patients that have a healing fracture, including the spine, pelvis, shoulder, ribs, vertebrae, or extremities.
  • Patients actively receiving any type of cancer treatment
  • Patients with active or previously diagnosed liver disease.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDURELymphatic Pump Osteopathic Manipulative Therapy

OMT is a series of manual pressure and physical stimulation among various parts of the body to stimulate fluid movement and immune response in patients with various symptoms and disease. This may help with conditions such as edema, clearance of infections, facilitate healing and circulation, and bolster the immune response. Specifically, the lymphatic pump type of OMT targets the head, neck, thoracic region, lumbar and sacral regions, pelvis, arms, legs, and abdomen.


Locations(1)

Geisinger 65-Forward, Buckhorn

Bloomsburg, Pennsylvania, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06495021


Related Trials